Cypress Medical supplier risk profile Q1-2026: 477 shipments, China-heavy sourcing, B-grade compliance score.
Cypress Medical imported 477 shipments from 63 suppliers across 8 countries in Q1 2026. China dominated the sourcing footprint at 73.4% of total shipments, followed by South Korea at 13.2%. The importer's trade centers on HS Chapter 34 (soaps and detergents) and Chapter 30 (pharmaceuticals), with Yangzhou Perfect Daily Chemicals and True Glove Factory as the largest suppliers. Supply chain visibility extends to tier-3 operations, with 31 entities mapped beyond immediate tier-2 relationships.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Cypress Medical registered zero sanctions watchlist hits and zero suppliers with documented forced-labor exposure under the Uyghur Forced Labor Prevention Act framework. The importer's B-grade risk score of 78 reflects baseline compliance standing absent these high-severity flags.
63 distinct tier-1 suppliers in Q1 2026
| YANGZHOU PERFECT DAILY CHEMICALS | China | 89 |
| TRUE GLOVE FACTORY | China | 64 |
| JIANERKANG MEDICAL | China | 44 |
| TRUE GLOVE FACTORY | South Korea | 41 |
| JIANGSU PROVINCE JIANERKANG MEDICAL | China | 26 |
| ALLMED MEDICAL LIM | China | 24 |
| RAPID AID VIETNAM | Vietnam | 19 |
| YANGZHOU PERFECT DAILY CHEMICALS | South Korea | 11 |
Share of Q1 2026 inbound shipments by source country
70 tier-2 + 31 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.